A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety, efficacy and tolerability of R940343 in the treatment of mild to moderate asthma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rigel Pharmaceuticals

Criteria

Inclusion Criteria:

• Clinical history of asthma

• Ability to perform spirometry

Exclusion Criteria:

• Chronic obstructive pulmonary disease or bronchiectasis

• Upper or lower respiratory infection